 FORT COLLINS, Colo., Sept. 2, 2021 PRNewswire -- Statera BioPharma, Inc. Nasdaq: STAB, a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced that President and CEO Michael K. 